Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 10, 2024

Primary Completion Date

March 7, 2025

Study Completion Date

March 7, 2025

Conditions

Diabetic NephropathiesType 2 Diabetes

Interventions

DRUG

Pirfenidone

Capsule Pirfenidone 1200mg/ day in divided doses for 3 months

OTHER

Placebo

2 Capsules 3 times a day for 3 months

Trial Locations (1)

King Edward Medical University, Lahore

All Listed Sponsors

lead

Sidrah Lodhi

OTHER

NCT06224790 - Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy | Biotech Hunter | Biotech Hunter